APVO · Aptevo Therapeutics Inc.
$2.94
-0.46 (-13.53%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“When considered in aggregate, these factors raise substantial doubt about our ability to continue as a going concern for the one-year period from the date of issuance of these financial statements.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.30M
Shares
1.80M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | |
| 8-K | 2026-08-14 | — | |
| 8-K | 2026-08-13 | 2026-08-12 | |
| DEF 14A | 2026-07-31 | — | |
| 8-K | 2026-07-27 | — | |
| 8-K | 2026-06-30 | 2026-06-29 | |
| 8-K | 2026-05-27 | 2026-05-25 | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-13 | — | |
| 8-K | 2026-05-06 | — | |
| 8-K | 2026-03-26 | — | |
| 10-K | 2026-03-26 | 2025-12-31 | |
| 8-K | 2026-03-11 | 2026-03-10 | |
| 8-K | 2026-02-19 | 2026-02-18 | |
| 8-K | 2026-02-03 | 2026-01-30 | |
| DEF 14A | 2026-01-26 | 2026-01-23 | |
| 8-K | 2026-01-09 | 2026-01-08 | |
| 8-K | 2025-12-29 | — | |
| 8-K | 2025-12-09 | — | |
| 8-K | 2025-11-06 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-09-16 | — | |
| 8-K | 2025-09-04 | — | |
| 10-Q | 2025-08-11 | 2025-06-30 | |
| 8-K | 2025-08-11 | — | |
| 8-K | 2025-07-24 | — | |
| DEF 14A | 2025-07-03 | 2025-07-24 | |
| 8-K | 2025-07-01 | — | |
| 8-K | 2025-06-30 | — | |
| 8-K | 2025-06-23 | — | |
| 8-K | 2025-06-20 | 2025-06-18 | |
| 8-K | 2025-06-20 | — | |
| 8-K | 2025-06-17 | 2025-06-16 | |
| 8-K | 2025-05-23 | — | |
| 8-K | 2025-05-22 | — | |
| 8-K | 2025-05-15 | — | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 8-K | 2025-04-29 | — | |
| 8-K | 2025-04-28 | — | |
| DEF 14A | 2025-04-25 | 2025-05-14 | |
| 8-K | 2025-04-22 | 2025-04-21 | |
| 8-K | 2025-04-04 | 2025-04-03 | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-02-14 | 2024-12-31 | |
| 8-K | 2025-02-14 | — | |
| 8-K | 2025-02-11 | — | |
| 8-K | 2024-12-12 | — | |
| 8-K | 2024-12-12 | — | |
| 8-K | 2024-12-04 | — |
Showing 1–50 of 160 filings
Key facts
CIK
1671584
CUSIP
03835L702
13F (30d)
10 filings
10 filers
Visit website
Investor relations